SCHEMBL2540736

SCHEMBL2540736

Cc1c(C(=O)Nc2ccc(S(C)(=O)=O)cc2)cn([C@H](C)[C@H](C)O)c1-c1ccccc1C(F)(F)F

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 6/20 0.79
PTPRC P08575 1/20 0.41
TRPV4 Q9HBA0 1/20 0.38
AVPR2 P30518 2/20 0.38
GPR27 Q9NS67 2/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
ELANE P08246 2/20 0.36
CCR8 P51685 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CDK1 P06493 1/20 0.35
CDK4 P11802 1/20 0.35
CCNB1 P14635 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
KDR P35968 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2357954 1.00 NR3C2 (0.79) NR3C2PTPRCTRPV4AVPR2GPR27
SCHEMBL13423545 0.90 NR3C2 (0.65) NR3C2PTPRCTRPV4AVPR2GPR27
SCHEMBL2358597 0.89 NR3C2 (1.00) NR3C2PTPRCTRPV4AVPR2GPR27
SCHEMBL2542480 0.89 NR3C2 (1.00) NR3C2PTPRCTRPV4AVPR2GPR27
SCHEMBL2359639 0.88 NR3C2 (0.83) NR3C2TRPV4AVPR2GPR27ELANE
SCHEMBL2543239 0.88 NR3C2 (0.83) NR3C2TRPV4AVPR2GPR27ELANE
SCHEMBL2439752 0.86 NR3C2 (0.66) NR3C2PTPRCAVPR2GPR27MAOA
SCHEMBL2439584 0.86 NR3C2 (0.79) NR3C2PTPRCAVPR2GPR27MAOA
SCHEMBL2441069 0.82 NR3C2 (0.71) NR3C2PTPRCAVPR2GPR27MAOA
SCHEMBL17646149 0.81 NR3C2 (0.81) NR3C2PTPRCAVPR2GPR27MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349997-B1 ATROPISOMERS OF (HYDROXYALKYL) PYRROLE DERIVATIVES EXELIXIS INC (US) 2015-08-12 EP claimed
US-8487117-B2 Atropisomers of (hydroxyalkyl) pyrrole derivatives EXELIXIS, INC. (US) 2013-07-16 US claimed
US-20110263673-A1 Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-10-27 US claimed
EP-2349997-B1 ATROPISOMERS OF (HYDROXYALKYL) PYRROLE DERIVATIVES EXELIXIS INC (US) 2015-08-12 EP disclosed
EP-2349997-B1 ATROPISOMERS OF (HYDROXYALKYL) PYRROLE DERIVATIVES EXELIXIS INC (US) 2015-08-12 EP disclosed
US-8487117-B2 Atropisomers of (hydroxyalkyl) pyrrole derivatives EXELIXIS, INC. (US) 2013-07-16 US disclosed
US-8487117-B2 Atropisomers of (hydroxyalkyl) pyrrole derivatives EXELIXIS, INC. (US) 2013-07-16 US disclosed
US-8487117-B2 Atropisomers of (hydroxyalkyl) pyrrole derivatives EXELIXIS, INC. (US) 2013-07-16 US disclosed
US-20110263673-A1 Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-10-27 US disclosed
US-20110263673-A1 Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-10-27 US disclosed
US-20110263673-A1 Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263673-A1 Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives ADRB3, HSD11B1, AKR1C3 NR3C2 62/4885PTPRC 3858/4885TRPV4 3145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.